Furthermore, since African descent have a lower response to ACE inhibitors compared to calcium blockers and β-adrenergic blocker anti-hypertensives [44], this decreased response could potentially contribute to the low COVID-19 prevalence and fatality in Africa. Here, ACE is linked to COVID-19.